March 3 (Reuters) - Mauna Kea Technologies SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES RECEIVES FDA CLEARANCE AND CE
MARKING FOR
ITS NEXT-GENERATION CELLVIZIO® PLATFORM
* MAUNA KEA TECHNOLOGIES SAS SAYS NEW CELLVIZIO® PLATFORM
INCLUDES
SIGNIFICANT IMPROVEMENTS AND WILL ENABLE MAJOR INNOVATIONS
* MAUNA KEA TECHNOLOGIES SAS ANNOUNCED THAT IT HAS OBTAINED
510(K) CLEARANCE (K193416) FROM THE U.S. FOOD AND DRUG
ADMINISTRATION (FDA) AND CE MARKING OF CELLVIZIO® ENDOMICROSCOPY
PLATFORM
Source text for Eikon: ID:nBw9Y6p8sa
Further company coverage: MKEA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))